Plasminogen activator inhibitor-1 modulates adipocyte differentiation

Area of Science:

• Metabolic research
• Cell biology
• Endocrinology

Background:

• Elevated plasminogen activator inhibitor-1 (PAI-1) is associated with obesity and insulin resistance.
• The specific role of PAI-1 within adipocytes remains unclear.

Purpose of the Study:

• To investigate the functional impact of PAI-1 on glucose uptake and adipocyte differentiation.
• To elucidate the underlying molecular mechanisms of PAI-1's effects in adipocytes.

Main Methods:

• Primary adipocytes from PAI-1(+/+) and PAI-1(-/-) mice were cultured and analyzed.
• 3T3-L1 adipocytes were treated with anti-PAI-1 antibodies or PAI-1 overexpression vectors.
• Gene and protein expression levels (e.g., glucose transporter 4, PPARgamma, adiponectin, resistin) were assessed.

Main Results:

• PAI-1 deficiency in primary adipocytes promoted differentiation, enhanced glucose uptake, and prevented dedifferentiation.
• PAI-1 deficiency upregulated glucose transporter 4, PPARgamma, and adiponectin, while downregulating resistin.
• Inhibition or absence of PAI-1 increased adipocyte differentiation and glucose uptake, mimicking the PAI-1(-/-) phenotype.

Conclusions:

• Absence or inhibition of PAI-1 protects adipocytes against insulin resistance.
• PAI-1's protective effects are mediated by promoting glucose uptake and adipocyte differentiation, linked to increased PPARgamma expression.
• PAI-1 may influence adipocyte function through modulation of plasmin activity and extracellular matrix components.